Top Markets
Coin of the day
Q-linea AB (publ) Q-linea AB (publ)

Q-linea AB (publ)

QLINEA
Rank in Stocks #31205
Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in... Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in developing diagnostic instruments and associated consumables for infection detection. The company crafts advanced in vitro diagnostic platforms, specifically engineered to identify infectious diseases. A key product is ASTar, an innovative system designed to rapidly assess antibiotic susceptibility in positive blood cultures. Q-linea's overarching mission is to deliver cutting-edge solutions to healthcare professionals.
Share Price
$2.09
Market Cap
$13.91M
Change (1 day)
7.47%
Change (1 year)
-62.33%
Country
SE
Trade Q-linea AB (publ) (QLINEA)

Category

Revenue for Q-linea AB (publ) (QLINEA)
Revenue in Aug 2026 TTM: 0
According to Q-linea AB (publ) latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Q-linea AB (publ) from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$11.03B -
US
$34.74B -
FR
- -
JP
$20.84B -
US
- -
CH